# A Study of Ibuprofen 250 mg / Acetaminophen 500 mg Comparing The Antipyretic Effects in Healthy Male Volunteers

> **NCT02761980** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 290 (actual)

## Conditions studied

- Fever

## Interventions

- **DRUG:** Ibuprofen 250 mg / Acetaminophen 500 mg
- **DRUG:** Ibuprofen 250 mg
- **DRUG:** Acetaminophen 500 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02761980
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-06
- **Primary completion:** 2017-12-06
- **Final completion:** 2017-12-06
- **Target enrollment:** 290 (ACTUAL)
- **Last updated:** 2018-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02761980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02761980, "A Study of Ibuprofen 250 mg / Acetaminophen 500 mg Comparing The Antipyretic Effects in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02761980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*